Related Experiment Video

Updated: Mar 22, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.7K

Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver

Seong Hwi Hong1, Jung Woo Eun2, Sung Kyung Choi1

  • 1Konkuk University Medical Center, School of Medicine, Konkuk University, Seoul 143-701, Korea.

Oncotarget
|April 16, 2016
PubMed

Insights

Targeting the epigenetic reader BRD4 shows promise for liver cancer therapy. Inhibiting BRD4 impacts cell cycle regulation via E2F2, offering a new therapeutic strategy for hepatocellular carcinoma (HCC).

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Epigenetic deregulation significantly influences cancer development.
  • Targeting epigenetic regulators, such as BRD4, is a promising cancer therapy strategy.
  • BRD4 inhibition has shown efficacy across various cancer types.

Purpose of the Study:

  • To investigate BRD4 as a therapeutic target in liver cancer (hepatocellular carcinoma, HCC).
  • To elucidate the molecular mechanisms underlying BRD4's role in HCC.

Main Methods:

  • Analysis of BRD4 expression in HCC patient cohorts and cell lines.
  • Inhibition of BRD4 using JQ1 in liver cancer cell lines.
  • Gene expression profiling and chromatin immunoprecipitation (ChIP) assays.
  • Loss-of-function studies to confirm target roles.

Main Results:

  • BRD4 is overexpressed in HCC and liver cancer cell lines.
  • BRD4 inhibition with JQ1 demonstrated anti-tumorigenic effects (cell cycle arrest, senescence, reduced colony formation).
  • E2F2 was identified as a direct downstream target of BRD4, crucial for its anti-tumor effects.
  • High E2F2 expression correlates with poor HCC prognosis.

Conclusions:

  • BRD4-E2F2-cell cycle regulation represents a novel molecular circuit in liver cancer.
  • BRD4 inhibition is a viable therapeutic strategy for HCC.
  • This study offers innovative insights for developing targeted liver cancer therapies.
Keywords:
BET proteinE2FJQ1epigenetic componentshepatocellular carcinoma (HCC)

More Related Videos

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.9K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K